For example, in studying TRAIL signaling for cancer resistance, a dynamic model was used to predict a novel target that significantly enhances cancer cell death [6], which was subsequently tested and validated experimentally in bulk or population cells [7] (Figure 1, A). The gene discussed is TNFSF10; the disease is cancer.